Dialysis of Drugs Guide |
この情報はストアのものより古い可能性がございます。 | ||||
価格 | 無料 | ダウンロード |
||
---|---|---|---|---|
ジャンル | メディカル | |||
サイズ | 7.6MB | |||
開発者 | Renal Pharmacy Consultants, LLC | |||
順位 |
| |||
リリース日 | 2013-03-01 11:22:58 | 評価 | 評価が取得できませんでした。 | |
互換性 | iOS 12.0以降が必要です。 iPhone、iPad および iPod touch 対応。 |
The guidelines contained in this application are designed to provide extensive, easy-to-read information regarding the dialyzability of drugs. Numerous literature sources have been used in preparing the guidelines. For many drugs, including newly-approved medications, investigational agents and medications available in other countries, there have been no dialysis pharmacokinetic studies. In some cases, the available data may conflict. Conditions of dialysis used in published studies may not reflect current dialysis practice and technology. Variations in the duration of dialysis, blood and dialysate flow rates, dialysis membranes, and whether peritoneal dialysis is continuous or intermittent, will all affect drug removal. These guidelines distinguish between conventional hemodialysis and high permeability (high-flux) hemodialysis where such data are available. No information is provided on drug dialyzability with continuous renal replacement therapy (CRRT) or with plasmapheresis. For additional information on specific drugs, the reader should consult the primary literature.
Users of this application are referred to www.renalpharmacyconsultants.com for background and explanatory material to assist in the interpretation of the tabular data. The website provides specific information about factors that influence drug dialyzability and special considerations, such as CRRT, plasmapheresis and drugs of abuse. Users must be familiar with this information prior to using the content of this application. The website also includes a table presenting sieving coefficient data from in vitro and in vivo evaluations, which can be used to predict dosing requirements in CRRT, and a table regarding removal of drugs of abuse.
The app requires a one year auto-renewing subscription to access application data. It will auto-renew unless you cancel the subscription, which you can do at any time.
Terms of Service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
更新履歴
In collaboration with ANNA
Users of this application are referred to www.renalpharmacyconsultants.com for background and explanatory material to assist in the interpretation of the tabular data. The website provides specific information about factors that influence drug dialyzability and special considerations, such as CRRT, plasmapheresis and drugs of abuse. Users must be familiar with this information prior to using the content of this application. The website also includes a table presenting sieving coefficient data from in vitro and in vivo evaluations, which can be used to predict dosing requirements in CRRT, and a table regarding removal of drugs of abuse.
The app requires a one year auto-renewing subscription to access application data. It will auto-renew unless you cancel the subscription, which you can do at any time.
Terms of Service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
更新履歴
In collaboration with ANNA
ブログパーツ第二弾を公開しました!ホームページでアプリの順位・価格・周辺ランキングをご紹介頂けます。
ブログパーツ第2弾!
アプリの周辺ランキングを表示するブログパーツです。価格・順位共に自動で最新情報に更新されるのでアプリの状態チェックにも最適です。
ランキング圏外の場合でも周辺ランキングの代わりに説明文を表示にするので安心です。
サンプルが気に入りましたら、下に表示されたHTMLタグをそのままページに貼り付けることでご利用頂けます。ただし、一般公開されているページでご使用頂かないと表示されませんのでご注意ください。
幅200px版
幅320px版
Now Loading...
「iPhone & iPad アプリランキング」は、最新かつ詳細なアプリ情報をご紹介しているサイトです。
お探しのアプリに出会えるように様々な切り口でページをご用意しております。
「メニュー」よりぜひアプリ探しにお役立て下さい。
Presents by $$308413110 スマホからのアクセスにはQRコードをご活用ください。 →
Now loading...